Home » PRIMAGEN ANNOUNCES NEW CLINICAL RESEARCH SERVICES FOR ANGIOGENESIS
PRIMAGEN ANNOUNCES NEW CLINICAL RESEARCH SERVICES FOR ANGIOGENESIS
After introducing its Cancer Biomarkers activities at the AACR in April this year, Primagen Holding BV, a molecular diagnostics company, will exhibit its products in booth #4463 at the American Society of Clinical Oncology (ASCO) meeting being held in Atlanta, Georgia, from June 2-6. The company is expanding its focus into the area of clinical oncology with new Clinical Research Services on its multiple mRNA expression markers and free-circulating mtDNA and mtRNA tests.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-24-2006/0004368145&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May